Clifford Swan Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.66M | Sell |
11,913
-2,780
| -19% | -$389K | 0.06% | 153 |
|
|
2025
Q4 | $1.8M | Sell |
14,693
-1,776
| -11% | -$216K | 0.06% | 156 |
|
|
2025
Q3 | $1.83M | Sell |
16,469
-18,402
| -53% | -$2.09M | 0.06% | 152 |
|
|
2025
Q2 | $3.87M | Sell |
34,871
-17,982
| -34% | -$1.91M | 0.14% | 118 |
|
|
2025
Q1 | $5.92M | Sell |
52,853
-7,361
| -12% | -$760K | 0.22% | 101 |
|
|
2024
Q4 | $5.56M | Sell |
60,214
-4,548
| -7% | -$409K | 0.2% | 106 |
|
|
2024
Q3 | $5.43M | Sell |
64,762
-1,170
| -2% | -$89.3K | 0.19% | 106 |
|
|
2024
Q2 | $4.52M | Sell |
65,932
-3,932
| -6% | -$262K | 0.17% | 112 |
|
|
2024
Q1 | $5.12M | Sell |
69,864
-1,178
| -2% | -$90.6K | 0.19% | 107 |
|
|
2023
Q4 | $5.76M | Sell |
71,042
-3,598
| -5% | -$280K | 0.22% | 100 |
|
|
2023
Q3 | $5.59M | Sell |
74,640
-1,040
| -1% | -$80K | 0.23% | 98 |
|
|
2023
Q2 | $5.83M | Sell |
75,680
-1,784
| -2% | -$142K | 0.24% | 100 |
|
|
2023
Q1 | $6.43M | Sell |
77,464
-7,977
| -9% | -$661K | 0.27% | 96 |
|
|
2022
Q4 | $7.34M | Sell |
85,441
-31,193
| -27% | -$2.47M | 0.32% | 91 |
|
|
2022
Q3 | $7.2M | Sell |
116,634
-18,060
| -13% | -$1.14M | 0.34% | 83 |
|
|
2022
Q2 | $8.32M | Sell |
134,694
-2,455
| -2% | -$152K | 0.36% | 82 |
|
|
2022
Q1 | $8.15M | Sell |
137,149
-12,575
| -8% | -$804K | 0.3% | 87 |
|
|
2021
Q4 | $10.9M | Sell |
149,724
-1,036
| -0.7% | -$71.4K | 0.38% | 75 |
|
|
2021
Q3 | $9.9M | Buy |
150,760
+1,989
| +1% | +$140K | 0.36% | 77 |
|
|
2021
Q2 | $10.3M | Buy |
148,771
+23,303
| +19% | +$1.56M | 0.39% | 76 |
|
|
2021
Q1 | $8.11M | Buy |
125,468
+37,199
| +42% | +$2.4M | 0.33% | 86 |
|
|
2020
Q4 | $5.14M | Sell |
88,269
-4,445
| -5% | -$268K | 0.22% | 104 |
|
|
2020
Q3 | $5.86M | Sell |
92,714
-263
| -0.3% | -$18.2K | 0.28% | 89 |
|
|
2020
Q2 | $7.15M | Sell |
92,977
-2,910
| -3% | -$223K | 0.37% | 79 |
|
|
2020
Q1 | $7.17M | Sell |
95,887
-2,912
| -3% | -$201K | 0.44% | 74 |
|
|
2019
Q4 | $6.42M | Sell |
98,799
-5,592
| -5% | -$364K | 0.31% | 88 |
|
|
2019
Q3 | $6.62M | Sell |
104,391
-5,418
| -5% | -$354K | 0.34% | 84 |
|
|
2019
Q2 | $7.42M | Sell |
109,809
-6,237
| -5% | -$410K | 0.39% | 80 |
|
|
2019
Q1 | $7.54M | Sell |
116,046
-847
| -0.7% | -$56.3K | 0.4% | 77 |
|
|
2018
Q4 | $7.31M | Sell |
116,893
-6,470
| -5% | -$452K | 0.44% | 70 |
|
|
2018
Q3 | $9.53M | Buy |
123,363
+7,034
| +6% | +$531K | 0.5% | 68 |
|
|
2018
Q2 | $8.24M | Sell |
116,329
-5,309
| -4% | -$375K | 0.46% | 74 |
|
|
2018
Q1 | $9.17M | Sell |
121,638
-2,074
| -2% | -$165K | 0.52% | 67 |
|
|
2017
Q4 | $8.86M | Sell |
123,712
-4,122
| -3% | -$313K | 0.48% | 72 |
|
|
2017
Q3 | $10.4M | Sell |
127,834
-3,535
| -3% | -$270K | 0.63% | 58 |
|
|
2017
Q2 | $9.3M | Sell |
131,369
-5,947
| -4% | -$396K | 0.58% | 61 |
|
|
2017
Q1 | $9.33M | Sell |
137,316
-11,266
| -8% | -$792K | 0.6% | 58 |
|
|
2016
Q4 | $10.6M | Sell |
148,582
-118,789
| -44% | -$8.83M | 0.71% | 50 |
|
|
2016
Q3 | $21.2M | Buy |
267,371
+16,494
| +7% | +$1.34M | 1.43% | 18 |
|
|
2016
Q2 | $20.9M | Buy |
250,877
+7,833
| +3% | +$695K | 1.45% | 19 |
|
|
2016
Q1 | $22.3M | Buy |
243,044
+86,336
| +55% | +$7.79M | 1.51% | 16 |
|
|
2015
Q4 | $15.9M | Buy |
156,708
+18,030
| +13% | +$1.88M | 1.09% | 28 |
|
|
2015
Q3 | $13.6M | Buy |
138,678
+105,868
| +323% | +$11.8M | 0.97% | 33 |
|
|
2015
Q2 | $3.84M | Buy |
+32,810
| New | +$3.59M | 0.26% | 85 |
|
Other funds holding GILD
VCM
VPM
Clifford Swan Investment Counsel's GILD Position: Q1 2026 in Review
Clifford Swan Investment Counsel reduced its Gilead Sciences (GILD) stake by 19% in Q1 2026, selling an estimated $389K and leaving 11,913 shares worth $1.66M. The position accounts for 0.06% of the portfolio, ranked #153.
Clifford Swan Investment Counsel first reported a position in GILD in Q2 2015 and has held it in 44 quarters since. The position peaked at $22.3M in Q1 2016. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Clifford Swan Investment Counsel held 11,913 shares of Gilead Sciences worth $1.66M as of Q1 2026.
- Clifford Swan Investment Counsel sold 2,780 Gilead Sciences shares in Q1 2026, an estimated $389K.
- Gilead Sciences made up 0.06% of Clifford Swan Investment Counsel's portfolio in Q1 2026, its #153 holding.
- Clifford Swan Investment Counsel first reported a position in Gilead Sciences in Q2 2015 and has held it in 44 quarters since.
- Clifford Swan Investment Counsel's Gilead Sciences position peaked at $22.3M in Q1 2016.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Clifford Swan Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.